We are studying a new oral treatment for children with certain kidney diseases to see if it is safe and effective. The trial will also evaluate how well children tolerate the medication and its impact on kidney function.
Health conditions and diseases that the clinical trial is designed to study and treat.
Proteinuric glomerular diseases are a group of kidney disorders that cause excess protein in the urine, leading to potential kidney damage. Common types include Focal Segmental Glomerulosclerosis (FSGS), Minimal Change Disease (MCD), and IgA Nephropathy (IgAN).
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
